-
Symbol
-
CLDI on NYSE
-
Investment type
-
Equity / Common Stock, $0.0001 par value
-
Latest Disclosed Shares Owned
-
0 shares
-
Security Ownership %
-
0%
Lincoln Alternative Strategies LLC ownership in Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI)
10 Feb 2026 - Lincoln Alternative Strategies LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI).
This represents 0% ownership of the company.
In their previous filing dated 27 Aug 2025, Lincoln Alternative Strategies LLC had reported owning 730,000 shares, indicating a decrease of +100%.
.